Hummingbird Bioscience
Clinical trials sponsored by Hummingbird Bioscience, explained in plain language.
-
New combo therapy aims to tame tough cancers
Disease control Recruiting nowThis study tests a new drug (HMBD-001) combined with standard treatments (cetuximab, with or without docetaxel) in people with advanced squamous cell cancers that have spread. The goal is to see if the combination is safe and can help control the cancer or slow its growth. About …
Phase: PHASE1, PHASE2 • Sponsor: Hummingbird Bioscience • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope for Hard-to-Treat cancers: first human trial launches
Disease control Recruiting nowThis study tests a new drug, HMBD-501, in people with advanced cancers (melanoma, lung, or breast) that have stopped responding to standard treatments. The goal is to find a safe dose and see if it can shrink tumors. About 180 adults will take part in two phases: first to check s…
Phase: PHASE1, PHASE2 • Sponsor: Hummingbird Bioscience • Aim: Disease control
Last updated May 04, 2026 16:20 UTC